This ridiculous theory is all that is left. The fundamentals of the company have created a situation where the stock is so undervalued that the only bad thing is made up nonsense about a bogeyman CEO who has spent his years trying to make his mark with this company and he obviously is going to be successful.
Unless you dont think he can sell two of the most well known highest dollar drugs on the market not to mention all the others and ones in development, trials, pending approval or already for sale
News 
Market Data 
Discover 
